No Data
*Special treat Ningke's performance is expected to be a loss in the first half of 2024.
Why We're Not Concerned Yet About Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 27% Share Price Plunge
*ST Ningke (600165.SH): The overall debt scale is 2.63 billion yuan, severely lacking in debt repayment funds and liquidity assets.
*ST Ningke (600165.SH) announced that the company's stock hit the limit down on June 13, 2024, trading volume of 2 million shares, accounting for 0.05% of total share capital. Trading will resume on June 14, 2024.
Special treat Ningke (600165.SH) publicly recruits and selects reorganization investors.
*Special treat Ningke (600165.SH) announcement, on May 30, 2024, the company received a notification from Ningxia Hui Autonomous Region...
Special treat Ningke (600165.SH): There is still a considerable gap to complete the true resumption of work and production.
ST Ningke (600165.SH) stated on the interactive platform on June 13th that the company's production recovery work is still in progress, and the output of trial production is low, there is still considerable gap from completing the real resumption of work and production. There is still uncertainty about whether the company can complete the resumption of work and production thoroughly and achieve sustainable normal production operation. Please refer to the announcement for information on resumption of work and production.
Special treat Ningke (600165.SH) appoints Zhu Canting as the general manager.
*Special Treat Ningke (600165.SH) announced that the board of directors has agreed to appoint Mr. Zhu Canting as the company's general manager, ...
No Data
